Pressrelease – Lund, April 23, 2026 – Monthly investor meeting on the 29th of April, 2026

Hamlet Biopharma
|
April 23, 2026

Hamlet BioPharma invites you to the monthly digital investors’ meeting to be held on the 29th of April 2026, at 12:00.

Please click on the link below to participate in the meeting:

http://us06web.zoom.us/j/83764124805?pwd=0dWpwsLs7u5I4YqQJJN0p3MuXLS6ay.1

 

For more information, please contact:

Catharina Svanborg, Chairman of the Board, Hamlet BioPharma, +46-709 42 65 49
catharina.svanborg@hamletpharma.com

Jakob Testad, CEO, Hamlet BioPharma, +46-708 48 42 10
jakob.testad@hamletbiopharma.com

www.hamletbiopharma.com
An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive
Pressreleases and Newsletters
© 2026
Hamlet BioPharma.